Quantcast

Latest Liver transplantation Stories

2014-08-05 11:43:07

University of Pittsburgh Schools of the Health Sciences Newly implemented screening guidelines and improved, highly effective drug therapies could make hepatitis C a rare disease in the United States by 2036, according to the results of a predictive model developed at the University of Pittsburgh Graduate School of Public Health. The results of the analysis, funded by the National Institutes of Health (NIH) and performed with the University of Texas MD Anderson Cancer Center, are...

2014-07-31 12:08:01

Dana-Farber Cancer Institute Study in NEJM reviews 10 years of data, argues for expansion of newborn screening Children born with so-called "bubble boy" disease have the best chance of survival if they undergo a hematopoietic stem cell transplant as soon after birth as possible, according to a detailed analysis of 10 years of outcome data by researchers at Dana-Farber/Boston Children's Cancer and Blood Disorders Center. These findings, the researchers say, argue for expanding newborn...

2014-07-29 23:13:49

San Antonio researcher leads national study that identified a combination of pills that cures 9 of 10 hepatitis C patients. San Antonio, TX (PRWEB) July 29, 2014 Researchers from The University of Texas Health Science Center at San Antonio, the Texas Liver Institute and other institutions have identified a combination of pills that cures 9 of 10 hepatitis C patients. The combination of the drugs sofosbuvir and simeprevir, with or without ribavirin, cured 93 percent of patients in 12...

2014-07-28 04:21:40

HORSHOLM, Denmark, July 28, 2014 /PRNewswire/ -- Veloxis Pharmaceuticals A/S (OMX: VELO) and Chiesi Farmaceutici S.p.A. today announced that the European Commission (EC) has granted marketing authorization for Envarsus(®) for the prevention of organ rejection in adult kidney and liver transplant patients in the European Union (EU). Key points:

2014-07-14 12:27:15

Special happenings at this year's event: liver recipient meets her donor's family for the first time, baseball legend Vinny Castilla hosts children's area DENVER, July 14, 2014 /PRNewswire/ -- One of Denver's most celebrated and attended cause-related 5Ks, the Donor Dash, is celebrating 15 years this summer. Taking place July 20 in Denver's historic Washington Park, the Donor Dash is a run/walk to honor the lives of organ, eye and tissue donors, celebrate the lives of recipients and...

2014-07-11 12:24:32

Hospital successfully transplants the first liver dialysis patient in the state HOUSTON, July 11, 2014 /PRNewswire-USNewswire/ -- Texas Children's Hospital is excited to announce the first use of an extracorporeal liver support therapy in Texas for children with acute liver failure. The hospital now offers the Molecular Adsorbent Recirculating System (MARS®), a liver dialysis therapy, which helped a 9-year-old patient with hepatic coma become healthy enough to be a candidate for...

2014-07-06 23:02:18

A team of doctors at Sir Ganga Ram Hospital, New Delhi consisting of Dr. Suresh Singhvi (Senior Consultant Hepatic & Pancreatic Surgery and Liver Transplant) and Dr. Sujay Shad (Senior Cardiac Surgeon) performed a rare surgery on a Nigerian patient, who had cancer of the liver that had spread to the heart. The patient reported to the hospital for a follow-up 15 months after the surgery and has recovered completely. New Delhi, India (PRWEB) July 06, 2014 Dr. Lubabatuyakuba Musa, a...

2014-06-28 13:57:32

TUM Virus infection supports organ acceptance Chronic hepatitis C virus infections are among the most common reasons for liver transplants. Because existing viruses also infect the new liver, the immune system is highly active there. Despite this, the new organ is not rejected, as scientists from the Helmholtz Zentrum München and the Technische Universität München (TUM) have now discovered. The long-term stimulation of the innate immune system by the virus actually increases the...

Hepatitis C treatment debate
2014-06-23 05:10:27

redOrbit Staff & Wire Reports - Your Universe Online A new combination therapy could cut treatment time for hepatitis C to just four weeks, but quicker recovery comes with a steep price, as the new medication is said to cost roughly $1,000 per pill. According to Reuters reporter Bill Berkrot, the treatment involves an experimental antiviral drug produced by Bristol-Myers Squibb and Sovaldi, a drug produced by Gilead Sciences Inc. that has reportedly outraged insurance companies and...

2014-05-29 08:29:58

SMIC and Renji Hospital holds The Children's Day Liver Transplant charity event SHANGHAI, May 29, 2014 /PRNewswire/ -- Semiconductor Manufacturing International Corporation ("SMIC"; NYSE: SMI; SEHK: 981), China's largest and most advanced semiconductor foundry, announced the donation of an additional 2 million yuan (including staff donations) to the Soong Ching Ling Foundation to help fund the SMIC Liver Transplant Program for Children. The announcement was made during The Children's...


Word of the Day
blee
  • Color; hue; complexion.
This word is Middle English in origin.
Related